| Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort A Darlix, G Louvel, J Fraisse, W Jacot, E Brain, M Debled, ... British journal of cancer 121 (12), 991-1000, 2019 | 190 | 2019 |
| Epidemiology for primary brain tumors: a nationwide population-based study A Darlix, S Zouaoui, V Rigau, F Bessaoud, D Figarella-Branger, ... Journal of neuro-oncology 131, 525-546, 2017 | 156 | 2017 |
| French brain tumor database: 5‐year histological results on 25 756 cases V Rigau, S Zouaoui, H Mathieu‐Daudé, A Darlix, A Maran, B Trétarre, ... Brain Pathology 21 (6), 633-644, 2011 | 143 | 2011 |
| Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases W Jacot, E Pons, JS Frenel, S Guiu, C Levy, PE Heudel, T Bachelot, ... Breast cancer research and treatment 157, 307-318, 2016 | 127 | 2016 |
| Survey on current cognitive practices within the European Low-Grade Glioma Network: towards a European assessment protocol A Rofes, E Mandonnet, J Godden, MH Baron, H Colle, A Darlix, ... Acta neurochirurgica 159, 1167-1178, 2017 | 110 | 2017 |
| Descriptive epidemiology of 13,038 newly diagnosed and histologically confirmed meningiomas in France: 2006–2010 S Zouaoui, A Darlix, V Rigau, H Mathieu-Daudé, F Bauchet, F Bessaoud, ... Neurochirurgie 64 (1), 15-21, 2018 | 101 | 2018 |
| Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national … P Fabbro-Peray, S Zouaoui, A Darlix, M Fabbro, J Pallud, V Rigau, ... Journal of Neuro-oncology 142, 91-101, 2019 | 86 | 2019 |
| Prolonged administration of adjuvant temozolomide improves survival in adult patients with glioblastoma A Darlix, C Baumann, V Lorgis, F Ghiringhelli, M Blonski, B Chauffert, ... Anticancer research 33 (8), 3467-3474, 2013 | 80 | 2013 |
| Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients M Blonski, J Pallud, C Gozé, E Mandonnet, V Rigau, L Bauchet, M Fabbro, ... Journal of Neuro-oncology 113, 267-275, 2013 | 70 | 2013 |
| French brain tumor database: general results on 40,000 cases, main current applications and future prospects S Zouaoui, V Rigau, H Mathieu-Daudé, A Darlix, F Bessaoud, ... Neuro-chirurgie 58 (1), 4-13, 2012 | 69 | 2012 |
| A probabilistic atlas of diffuse WHO grade II glioma locations in the brain S Parisot, A Darlix, C Baumann, S Zouaoui, Y Yordanova, M Blonski, ... PloS one 11 (1), e0144200, 2016 | 60 | 2016 |
| IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas A Darlix, J Deverdun, N Menjot de Champfleur, F Castan, S Zouaoui, ... Journal of Neuro-Oncology 133, 37-45, 2017 | 58 | 2017 |
| Assessment and treatment relevance in elderly glioblastoma patients L Bauchet, S Zouaoui, A Darlix, N Menjot de Champfleur, E Ferreira, ... Neuro-oncology 16 (11), 1459-1468, 2014 | 50 | 2014 |
| Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients A Darlix, PJ Lamy, E Lopez-Crapez, AL Braccini, N Firmin, G Romieu, ... BMC cancer 16, 1-14, 2016 | 47 | 2016 |
| External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience G Griguolo, W Jacot, E Kantelhardt, MV Dieci, C Bourgier, C Thomssen, ... The Breast 37, 36-41, 2018 | 43 | 2018 |
| Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France S Zouaoui, A Darlix, P Fabbro-Peray, H Mathieu-Daudé, V Rigau, ... Neurosurgical review 37, 415-424, 2014 | 43 | 2014 |
| Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort D Pasquier, A Darlix, G Louvel, J Fraisse, W Jacot, E Brain, A Petit, ... European Journal of Cancer 125, 22-30, 2020 | 39 | 2020 |
| Clinicopathological and treatment‐associated prognostic factors in patients with breast cancer leptomeningeal metastases in relation to tumor biology G Griguolo, S Pouderoux, MV Dieci, W Jacot, C Bourgier, F Miglietta, ... The Oncologist 23 (11), 1289-1299, 2018 | 39 | 2018 |
| Serum NSE, MMP‐9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases? A Darlix, PJ Lamy, E Lopez‐Crapez, AL Braccini, N Firmin, G Romieu, ... International journal of cancer 139 (10), 2299-2311, 2016 | 39 | 2016 |
| Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database M Carausu, M Carton, A Darlix, D Pasquier, M Leheurteur, M Debled, ... ESMO open 6 (3), 100150, 2021 | 34 | 2021 |
